In order to evaluate the potential effect of KDM5A on osteosarcoma cell proliferation in vivo, the CRISPR/Cas9 system was used to knock out KDM5A in 143B cell lines (Fig. 5A). This evidence concerns the gene KDM5A and osteosarcoma.